Loading insider details...
Latest Form 4 (Aug 14, 2026): Purchase of 2,525,252 OTLK shares, $2.50M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 2,525,252 | $2.50M |
| Jun 2, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 8,539,709 | $5.00M |
| May 28, 2025 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 4,285,714 | $6.00M |
| Jan 22, 2025 | Outlook Therapeutics, Inc. (OTLK) | Disposition to Issuer | 3,458,571 | n/a |
| Mar 20, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 2,305,714 | n/a |
| Dec 29, 2022 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 14,230,418 | $12.50M |
| Feb 1, 2022 | Outlook Therapeutics, Inc. (OTLK) | Other (see footnotes) | 2,500,000 | $3.13M |
| Dec 1, 2021 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 16,000,000 | $20.00M |
| Feb 11, 2021 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 1,013,627 | $1.01M |
| Feb 2, 2021 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 8,360,000 | $8.36M |